• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

叉头结构域抑制剂(FDI)的构效关系研究:卤键结合相互作用的重要性。

A structure-activity relationship study of Forkhead Domain Inhibitors (FDI): The importance of halogen binding interactions.

机构信息

Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada.

Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada.

出版信息

Bioorg Chem. 2019 Dec;93:103269. doi: 10.1016/j.bioorg.2019.103269. Epub 2019 Sep 12.

DOI:10.1016/j.bioorg.2019.103269
PMID:31654840
Abstract

The Forkhead boX M1 (FOXM1) protein is an essential transcription factor required for the normal activation of human cell cycle. However, increasing evidence supports a correlation between FOXM1 overexpression and the onset of several types of cancer. Based on a previously reported molecular modeling and molecular dynamics simulations (MD) study, we hypothesized the role of an essential halogen-bonding interaction between the 4-fluorophenyl group in the forkhead domain inhibitor-6 (FDI-6) and an Arg297 residue inside the FOXM1-DNA binding domain (DBD). To prove the importance of this binding interaction, we synthesized and screened ten FDI-6 derivatives possessing different groups at the 4-fluorophenyl position of the lead molecule. Briefly, we found that derivatives possessing a 4-chlorophenyl, 4-bromophenyl, or a 4-iodophenyl group, were equipotent to the original 4-fluorophenyl moiety present in FDI-6, whereas derivatives without this 4-halogen moiety were inactive. We also observed that positional isomers in which the halogen was relocated to positions 2- or 3- on the phenyl group were significantly less active. These results provide evidence to support the essential role of a 4-halophenyl bonding interaction, with the Arg297 residue in the FOXM1-DBD, to exert inhibition of transcriptional activity.

摘要

叉头框蛋白 M1(FOXM1)蛋白是一种必需的转录因子,对于人类细胞周期的正常激活是必需的。然而,越来越多的证据支持 FOXM1 过表达与几种类型的癌症的发生之间存在相关性。基于先前报道的分子建模和分子动力学模拟(MD)研究,我们假设在叉头域抑制剂-6(FDI-6)的 4-氟苯基和 FOXM1-DNA 结合域(DBD)内的 Arg297 残基之间存在必需的卤素键相互作用。为了证明这种结合相互作用的重要性,我们合成并筛选了十个具有不同取代基的 FDI-6 衍生物,这些取代基位于先导分子的 4-氟苯基位置。简而言之,我们发现具有 4-氯苯基、4-溴苯基或 4-碘苯基取代基的衍生物与 FDI-6 中存在的原始 4-氟苯基部分具有同等效力,而没有这种 4-卤代部分的衍生物则没有活性。我们还观察到,卤素被重新定位到苯基的 2-或 3-位的位置异构体的活性显著降低。这些结果提供了证据,支持在 FOXM1-DBD 中,Arg297 残基与 4-卤代苯基键相互作用对于发挥转录活性抑制作用是必需的。

相似文献

1
A structure-activity relationship study of Forkhead Domain Inhibitors (FDI): The importance of halogen binding interactions.叉头结构域抑制剂(FDI)的构效关系研究:卤键结合相互作用的重要性。
Bioorg Chem. 2019 Dec;93:103269. doi: 10.1016/j.bioorg.2019.103269. Epub 2019 Sep 12.
2
FOXM1 Inhibitors as Potential Diagnostic Agents: First Generation of a PET Probe Targeting FOXM1 To Detect Triple-Negative Breast Cancer in vitro and in vivo.FOXM1抑制剂作为潜在的诊断剂:靶向FOXM1的第一代PET探针用于体外和体内检测三阴性乳腺癌
ChemMedChem. 2021 Dec 14;16(24):3720-3729. doi: 10.1002/cmdc.202100279. Epub 2021 Oct 22.
3
Untying the knot of transcription factor druggability: Molecular modeling study of FOXM1 inhibitors.解开转录因子可成药难题:FOXM1抑制剂的分子建模研究
J Mol Graph Model. 2018 Mar;80:197-210. doi: 10.1016/j.jmgm.2018.01.009. Epub 2018 Jan 31.
4
Molecular mechanism of Forkhead box M1 inhibition by thiostrepton in breast cancer cells.叉头框转录因子 M1 被噻唑霉素抑制在乳腺癌细胞中的分子机制。
Oncol Rep. 2019 Sep;42(3):953-962. doi: 10.3892/or.2019.7225. Epub 2019 Jul 8.
5
SP1-independent inhibition of FOXM1 by modified thiazolidinediones.噻唑烷二酮类化合物通过非 SP1 依赖性途径抑制 FOXM1。
Eur J Med Chem. 2021 Jan 1;209:112902. doi: 10.1016/j.ejmech.2020.112902. Epub 2020 Oct 10.
6
[Forkhead domain inhibitor-6 (FDI-6) increases apoptosis and inhibits invasion and migration of laryngeal carcinoma cells by down-regulating nuclear FoxM1].[叉头结构域抑制剂-6(FDI-6)通过下调核内FoxM1增加喉癌细胞凋亡并抑制其侵袭和迁移]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017 May;33(5):611-616.
7
Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells.在结肠癌细胞中,刺猬信号通路的异常激活通过叉头框M1的转录激活促进细胞增殖。
J Exp Clin Cancer Res. 2017 Feb 2;36(1):23. doi: 10.1186/s13046-017-0491-7.
8
A drug repurposing study identifies novel FOXM1 inhibitors with in vitro activity against breast cancer cells.药物重定位研究鉴定出新型 FOXM1 抑制剂,对乳腺癌细胞具有体外活性。
Med Oncol. 2024 Jun 25;41(8):188. doi: 10.1007/s12032-024-02427-0.
9
The cell-penetrating FOXM1 N-terminus (M1-138) demonstrates potent inhibitory effects on cancer cells by targeting FOXM1 and FOXM1-interacting factor SMAD3.穿膜转录因子 FOXM1 N 端(M1-138)通过靶向 FOXM1 和 FOXM1 相互作用因子 SMAD3,对癌细胞表现出强大的抑制作用。
Theranostics. 2019 Apr 25;9(10):2882-2896. doi: 10.7150/thno.32693. eCollection 2019.
10
Loss of Forkhead box M1 promotes erythropoiesis through increased proliferation of erythroid progenitors.叉头框蛋白M1缺失通过增加红系祖细胞增殖促进红细胞生成。
Haematologica. 2017 May;102(5):826-834. doi: 10.3324/haematol.2016.156257. Epub 2017 Feb 2.

引用本文的文献

1
Novel benzothiazole/benzothiazole thiazolidine-2,4-dione derivatives as potential FOXM1 inhibitors: In silico, synthesis, and in vitro studies.新型苯并噻唑/苯并噻唑噻唑烷-2,4-二酮衍生物作为潜在的叉头框蛋白M1(FOXM1)抑制剂:计算机模拟、合成及体外研究
Arch Pharm (Weinheim). 2024 Dec;357(12):e2400504. doi: 10.1002/ardp.202400504. Epub 2024 Sep 24.
2
A drug repurposing study identifies novel FOXM1 inhibitors with in vitro activity against breast cancer cells.药物重定位研究鉴定出新型 FOXM1 抑制剂,对乳腺癌细胞具有体外活性。
Med Oncol. 2024 Jun 25;41(8):188. doi: 10.1007/s12032-024-02427-0.
3
FDI-6 inhibits VEGF-B expression in metastatic breast cancer: a combined in vitro and in silico study.
FDI-6抑制转移性乳腺癌中VEGF-B的表达:一项体外和计算机模拟相结合的研究
Mol Divers. 2025 Apr;29(2):1069-1078. doi: 10.1007/s11030-024-10891-z. Epub 2024 Jun 9.
4
Increased FOXM1 Expression was Associated with the Prognosis and the Recruitment of Neutrophils in Endometrial Cancer.FOXM1 表达增加与子宫内膜癌的预后和中性粒细胞募集有关。
J Immunol Res. 2023 Apr 29;2023:5437526. doi: 10.1155/2023/5437526. eCollection 2023.
5
Heat shock proteins and cancer: The FoxM1 connection.热休克蛋白与癌症:FoxM1 的关联。
Biochem Pharmacol. 2023 May;211:115505. doi: 10.1016/j.bcp.2023.115505. Epub 2023 Mar 15.
6
Identification of new small molecules as dual FoxM1 and Hsp70 inhibitors using computational methods.利用计算方法鉴定新型小分子作为FoxM1和Hsp70双重抑制剂
Res Pharm Sci. 2022 Oct 29;17(6):635-656. doi: 10.4103/1735-5362.359431. eCollection 2022 Dec.
7
CDI Exerts Anti-Tumor Effects by Blocking the FoxM1-DNA Interaction.艰难梭菌感染通过阻断FoxM1与DNA的相互作用发挥抗肿瘤作用。
Biomedicines. 2022 Jul 11;10(7):1671. doi: 10.3390/biomedicines10071671.
8
Structure-Activity Relationship of -Phenylthieno[2,3-]pyridine-2-carboxamide Derivatives Designed as Forkhead Box M1 Inhibitors: The Effect of Electron-Withdrawing and Donating Substituents on the Phenyl Ring.设计为叉头框M1抑制剂的α-苯基噻吩并[2,3-b]吡啶-2-甲酰胺衍生物的构效关系:苯环上吸电子和供电子取代基的影响。
Pharmaceuticals (Basel). 2022 Feb 24;15(3):283. doi: 10.3390/ph15030283.
9
Berberine Inhibits FOXM1 Dependent Transcriptional Regulation of POLE2 and Interferes With the Survival of Lung Adenocarcinoma.小檗碱抑制FOXM1依赖的POLE2转录调控并干扰肺腺癌的生存。
Front Pharmacol. 2022 Jan 31;12:775514. doi: 10.3389/fphar.2021.775514. eCollection 2021.
10
The Anticancer Effects of FDI-6, a FOXM1 Inhibitor, on Triple Negative Breast Cancer.FOXM1 抑制剂 FDI-6 对三阴性乳腺癌的抗癌作用。
Int J Mol Sci. 2021 Jun 22;22(13):6685. doi: 10.3390/ijms22136685.